Skip to content

Comparing the effects of dexmedetomidine and remifentanil in pain control

Comparison of the effect of Dexmedetomidine compared to intravenous remifentanil in controlling pain after lumbar spine surgery

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241030063548N1
Enrollment
92
Registered
2024-11-14
Start date
2024-11-16
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comparison of remifentanil and dexmedetomedin in pain control after lumbar spine surgery.

Interventions

Intervention 1: Intervention group: After anesthesia induction in a similar plan, patients will receive dexmedetomidine (Precedex) at a dose of 0.01 µg / kg per hour as an infusion. Intervention 2: In

Sponsors

Karaj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age between 18 and 65 years Patient consent to participate in the study Candidates for lumbar surgery require general anesthesia History

Exclusion criteria

Exclusion criteria: Heart blocks such as atrial, intraventricular or sinus-atrial block Heart rate less than 50 or heart failure with ejection fraction less than 40% Epilepsy or convulsions Obstructive sleep apnea syndrome Patients with unpredictable events such as severe bleeding Pregnancy or breastfeeding drop in blood pressure

Design outcomes

Primary

MeasureTime frame
The study "comparison of the effect of two drugs remifentanil and dexmedomedin in reducing pain after lumbar spine surgery" the primary outcome of pain reduction measured at different times. Timepoint: Measurement: during in recovery, 2 , 8 and 24 hours after the surgery , It is measured , in addition to pain control, secondary outcomes such as: nausea and vomiting are measured. Method of measurement: Questionnaire: Measuring the Visual Analogue Scale (VAS) and scoring the Ramsy Sedation Assessment Scale (RSAS) in compliance with research ethics and the approval of the ethics committee.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Mardani hossein abadi

Karaj University of Medical Sciences

mahdialihosseini7@gmail.com+98 21 3419 8204

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026